Skip to content

CRISPR

CRISPR-Cas is a gene-editing technology that uses programmable enzymes to cut and modify DNA, widely used in research, medicine, and biotechnology.

Known aliases

  • CRISPR-Cas
  • CRISPR gene editing
  • CRISPR screens

Current stories

scienceOne report1 publisher

Claude found CRISPR-like repeats beside a phage reverse transcriptase gene during a search for something else

Anthropic says Claude found a CRISPR-like repeat array beside a reverse transcriptase gene in a bacteriophage, function unknown. The company's researchers say they have no idea yet what it does, so the finding is a lead for lab validation.

Reality

Evidence25
Adoption
Not scored
Hype gap−10
Incentives
Not scored
Confidence55
scienceConfirmed2 publishers

Columbia team finds bacterial antiviral enzyme that adds repeat DNA the way telomerase does

Columbia researchers report DRT10, a bacterial antiviral system whose reverse transcriptase writes repeat DNA by a route that parallels human telomerase. The Nature abstract reports bacterial biochemistry, structures and phylogenetics, and Sternberg calls the editing and telomere-repair uses early days.

Publishers:nature.com phys.org

Reality

Evidence68
Adoption
Not scored
Hype gap+25
Incentives
Not scored
Confidence70
scienceOne report1 publisher

Researcher who shared drafts with Claude questions Anthropic's enzyme-discovery claim

Copenhagen PhD candidate Mario Rodríguez Mestre questions whether Anthropic's Claude independently found an enzyme family his team has studied since 2022. Credit for the find is unsettled, and the case shows how little a scientist can check once unpublished work has gone into a commercial chatbot.

Publishers:phys.org

Reality

Evidence38
Adoption
Not scored
Hype gap+45
Incentives60
Confidence40
productOne report1 publisher

Anthropic's Crispr-like find from 950 Claude agents still waits on the wet lab

Anthropic says about 950 Claude agents found an enzyme system reminiscent of Crispr in 21.5 hours, backed so far by one unreviewed lab experiment. Scientists credit the speed of the search, so a lab can budget for faster triage today while the bench works out what the enzyme does.

Publishers:wired.com

Reality

Evidence35
Adoption
Not scored
Hype gap+45
Incentives70
Confidence50
buildConfirmed5 publishers

Anthropic's 950 Claude agents spent 210 million tokens to hand biologists 20 enzyme leads

Anthropic ran about 950 Claude agents for 21 hours on 210 million tokens to cut over 200,000 reverse transcriptases to 20 lab candidates. Human scientists kept the bench work, so lab capacity sets how fast those leads get tested.

Perspective Coverage

5 publishers
Builder
Builder 45%
Operator
Operator 36%
Investor
Investor 19%

Reality

Evidence46
Adoption
Not scored
Hype gap+48
Incentives80
Confidence64
productOne report1 publisher

United Therapeutics launches world's first pig-kidney clinical trial

United Therapeutics is sponsoring the first xenotransplant clinical trial. Its first patient got a 10-edit pig kidney at NYU Langone in November. The longest a gene-edited pig kidney has worked in a person is 271 days, against years or decades for a human donor organ.

Publishers:gizmodo.com

Reality

Evidence52
Adoption31
Hype gap+22
Incentives72
Confidence44
leadershipOne report1 publisher

Anthropic's new biology lab and 950 Claude agents together found a new enzyme system in 21 hours

The company's new life sciences group says agents working from a single prompt flagged an enzyme system with CRISPR-like DNA repeats, and its scientists are still running experiments to find out what the system actually does.

Publishers:anthropic.com

Reality

Evidence42
Adoption20
Hype gap+22
Incentives85
Confidence52
scienceOne report1 publisher

Broad and MIT engineer cells to bud their own RNA into the culture medium

A repurposed retroviral shell protein lets a culture report its own gene activity again and again instead of once, so a single well becomes its own before-and-after control, at population-average resolution.

Publishers:phys.org

Reality

Evidence55
Adoption15
Hype gap+25
Incentives78
Confidence58
scienceOne report1 publisher

A deliberately mismatched primer holds CRISPR back until a one-tube test has enough target

HKUST and CUHK researchers report in Nature Communications that thermodynamic timing lets amplification and CRISPR detection share a single sealed tube, reaching 1 aM in 30 minutes. The announcement leaves out the clinical denominator.

Publishers:phys.org

Reality

Evidence58
Adoption10
Hype gap+32
Incentives74
Confidence55
scienceConfirmed3 publishers

Six mice per arm put the disputed PTBP1 conversion route back in the argument

Peisheng Xu's group degraded the PTBP1 protein with antibodies ferried past the blood-brain barrier, and human astrocytes in a dish turned into firing neurons. In living mice, the lineage question is still open.

Perspective Coverage

3 publishers
Builder
Builder 45%
Operator
Operator 32%
Investor
Investor 23%

Reality

Evidence44
Adoption6
Hype gap+34
Incentives63
Confidence61
scienceOne report1 publisher

METTL3 turns out to be part of mitosis, which makes its inhibitors a scheduling problem

A Yale-led study in Molecular Cell puts the RNA-tagging enzyme inside the cell division switch. Oncology programmes have been explaining what its drugs do a different way.

Publishers:phys.org

Reality

Evidence52
Adoption
Not scored
Hype gap+32
Incentives62
Confidence45
scienceOne report1 publisher

A gene-ranking tool that disagrees with GWAS, and 21 asthma genes to argue about

DANDELION ranks genes by position in trans-regulatory networks rather than distance from a variant. Its asthma shortlist survived CRISPR screens and mouse models. The denominator is missing.

Publishers:genengnews.com

Reality

Evidence58
Adoption
Not scored
Hype gap+28
Incentives68
Confidence52
scienceOne report1 publisher

Sex becomes a setting in cloning: a CRISPR cut makes female clones of a male mouse

Deleting the Y chromosome from cloned male embryos produced fertile female mice that bred with their male clone brothers. Whether XO animals stay fertile in other species is the constraint.

Publishers:newscientist.com

Reality

Evidence54
Adoption10
Hype gap+14
Incentives46
Confidence55